Your browser doesn't support javascript.
loading
Drug sales confirm clinical advantage of multi-target inhibition of drug escapes by anticancer kinase inhibitors.
Chen, Shangying; Yang, Sheng Yong; Chen, Zhe; Tan, Ying; Jiang, Yu Yang; Chen, Yu Zong.
Afiliación
  • Chen S; The State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, Tsinghua University Shenzhen Graduate School, Shenzhen Technology and Engineering Laboratory for Personalized Cancer Diagnostics and Therapeutics, Shenzhen Kivita Innovative Drug Discovery Institute, Guangdong, P.
  • Yang SY; Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China.
  • Chen Z; Zhejiang Key Laboratory of Gastro-intestinal Pathophysiology, Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Tan Y; The State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, Tsinghua University Shenzhen Graduate School, Shenzhen Technology and Engineering Laboratory for Personalized Cancer Diagnostics and Therapeutics, Shenzhen Kivita Innovative Drug Discovery Institute, Guangdong, P.
  • Jiang YY; The State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Biology, Tsinghua University Shenzhen Graduate School, Shenzhen Technology and Engineering Laboratory for Personalized Cancer Diagnostics and Therapeutics, Shenzhen Kivita Innovative Drug Discovery Institute, Guangdong, P.
  • Chen YZ; Bioinformatics and Drug Design Group, Department of Pharmacy, National University of Singapore, Singapore, Singapore.
Drug Dev Res ; 80(2): 246-252, 2019 03.
Article en En | MEDLINE | ID: mdl-30422335
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida / Neoplasias / Antineoplásicos Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Drug Dev Res Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Terapia Molecular Dirigida / Neoplasias / Antineoplásicos Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Drug Dev Res Año: 2019 Tipo del documento: Article